103 related articles for article (PubMed ID: 9342488)
1. Immunoglobulin G subclasses and susceptibility to allosensitization in humans.
Okasha K; Saxena A; el Bedowey MM; Shoker AS
Clin Nephrol; 1997 Sep; 48(3):165-72. PubMed ID: 9342488
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin-G subclass antidonor reactivity in transplant recipients.
Gao ZH; McAlister VC; Wright JR; McAlister CC; Peltekian K; MacDonald AS
Liver Transpl; 2004 Aug; 10(8):1055-9. PubMed ID: 15390333
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
[TBL] [Abstract][Full Text] [Related]
4. In vitro IgG1 alloreactive antibody production by circulating memory cells in humans.
Okasha K; Yang H; Shoker AS
Clin Nephrol; 1998 Jul; 50(1):21-7. PubMed ID: 9710343
[TBL] [Abstract][Full Text] [Related]
5. Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection.
Poggio ED; Augustine JJ; Clemente M; Danzig JM; Volokh N; Zand MS; Hricik DE; Heeger PS
Transplantation; 2007 Apr; 83(7):847-52. PubMed ID: 17460554
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients.
Akalin E; Ames S; Sehgal V; Fotino M; Daly L; Murphy B; Bromberg JS
Transplantation; 2003 Nov; 76(10):1444-7. PubMed ID: 14657683
[TBL] [Abstract][Full Text] [Related]
7. Differences in humoral immunity between a non-rejection group and a rejection group after ABO-incompatible renal transplantation.
Ishida H; Tanabe K; Ishizuka T; Furusawa M; Miyamoto N; Ishikawa N; Shirakawa H; Shimmura H; Ishii D; Nozaki D; Setoguchi K; Toma H
Transplantation; 2006 Mar; 81(5):665-71. PubMed ID: 16534466
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
Jordan SC; Tyan D; Stablein D; McIntosh M; Rose S; Vo A; Toyoda M; Davis C; Shapiro R; Adey D; Milliner D; Graff R; Steiner R; Ciancio G; Sahney S; Light J
J Am Soc Nephrol; 2004 Dec; 15(12):3256-62. PubMed ID: 15579530
[TBL] [Abstract][Full Text] [Related]
9. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
10. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
[TBL] [Abstract][Full Text] [Related]
11. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P
Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175
[TBL] [Abstract][Full Text] [Related]
12. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
13. The significance of the IgG anti-B-cell crossmatch on renal transplant outcome.
Ghasemian SR; Light JA; Currier CB; Sasaki T; Aquino A; Rees J; Ward W; Carr J
Clin Transplant; 1997 Oct; 11(5 Pt 2):485-7. PubMed ID: 9361946
[TBL] [Abstract][Full Text] [Related]
14. Hyperacute rejection of living related kidney grafts caused by endothelial cell-specific antibodies: case reports.
Grandtnerová B; Mäcková N; Hovoricová B; Jahnová E
Transplant Proc; 2008 Sep; 40(7):2422-4. PubMed ID: 18790254
[TBL] [Abstract][Full Text] [Related]
15. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
Krishnamurthy G; Kher V; Naik S
Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
[TBL] [Abstract][Full Text] [Related]
16. Immunological follow-up of 41 renal allograft recipients.
Birkeland SA
Scand J Urol Nephrol; 1976; (31 Suppl):3-37. PubMed ID: 792987
[TBL] [Abstract][Full Text] [Related]
17. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
[TBL] [Abstract][Full Text] [Related]
18. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin levels and lymphocyte subsets following cardiac operations: further evidence for a T-helper cell shifting.
Lante W; Franke A; Weinhold C; Markewitz A
Thorac Cardiovasc Surg; 2005 Feb; 53(1):16-22. PubMed ID: 15692913
[TBL] [Abstract][Full Text] [Related]
20. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]